Kratos Cuts Deepest as Analysts Slash Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Among the unmanned-systems and defense-tech cluster, KTOS is absorbing a concentrated wave of analyst target reductions that stands apart from most of its closest peers, even as the stock itself has held up better on a weekly basis than names like RCAT and AIRO.
The analyst story this week is unusually busy and uniformly cautious on price. Goldman Sachs cut its target to $77 from $88 on October 12, keeping a Buy rating. Citizens followed on October 19, trimming from $105 to $70 while maintaining Market Outperform. Jefferies had already moved to $68 from $80 at the start of October. Macquarie and Barclays both initiated fresh coverage in the past two weeks, both at Outperform or Overweight, but with targets of $70 and $90 respectively, well below where the stock was trading even a month ago. The consensus price target now stands at $96.88, which implies substantial upside from the current $38.96 close. That gap is notable: the stock has fallen 18% over the past month, and analysts are marking targets down to meet it rather than abandoning their constructive ratings. Every recent change keeps a positive recommendation intact. The bear case centres on government budget dependency (roughly 68% of revenue from federal customers), fixed-price contract risk, and free cash flow conversion pressure as capex-heavy programs ramp. The bull case rests on strategic positioning in drone, hypersonics, and space systems, a record pipeline, and a revenue growth rate that reached 23% year-over-year in the most recent quarter.
Short positioning is rising but remains well short of extreme. Short interest has climbed to 6.2% of the free float, up 3.4% on the week and now at its highest point in the past six weeks, having ticked up from around 9.1 million shares in early October to 10.4 million. The direction of travel is worth watching, but the absolute level does not place Kratos among the heavily contested names in the sector. The borrow market confirms as much: availability is loose at 879%, meaning there are nearly nine times as many shares available to lend as are currently borrowed, and though that availability figure has tightened from above 1,000% earlier this month, it remains well above the 52-week low of 459%. Cost to borrow has jumped 32% on the week to 0.34%, but that is still a low absolute rate. Options tell a different story from the short book: the put/call ratio has fallen to 0.35, sitting near the bottom of its 52-week range and almost one standard deviation below its 20-day average of 0.40. Call volume is dominating, which points to more speculative interest in a recovery than to hedging pressure.
The peer picture adds context to the week's relative performance. Kratos fell 3.4% over five days, which looks moderate against a median weekly decline of around 7.7% across its closest correlates. RCAT dropped 12.8% on the week and AIRO fell 12.3%, both considerably steeper. AVAV gave back 7.5%. The one notable exception in the group was KRMN, which gained 16.2% on the week, diverging sharply from the broader sector softness. Year-to-date Kratos is still down around 48%, in line with the weakest names in the group rather than the steadier large-cap primes like Lockheed Martin and RTX, which have held positive or near-flat territory.
On insider activity, all recent trades are sales executed under pre-arranged 10b5-1 plans, so they carry limited signal about near-term conviction. The STC division president sold shares on October 15, and the CFO and general counsel both sold in mid-September. Net insider activity over the trailing 90 days amounts to roughly $23.9 million in net sales across 382,000 shares. Because every transaction disclosed was plan-driven, the pattern reflects scheduled liquidation rather than a discretionary read on the stock.
Retail attention has picked up noticeably. Wikipedia page views for Kratos are running about 1.8 standard deviations above their 90-day baseline, the highest attention reading in recent months. That likely reflects the sharp price decline attracting broader interest rather than any specific product or contract news, and it is an attention signal, not a revenue indicator.
Earnings are due November 4. The prior two quarters each produced double-digit single-day gains, with the stock rising above 10% the day after each release and extending further over the following week. Whether the November print can repeat that pattern will depend on whether the budget and execution concerns embedded in current analyst targets are reflected in guidance.
Stocks in this article
See the live data behind this article on ORTEX.
Open KTOS on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 19:42
- Data as of
- 21 Oct 2026, 19:32
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.